Objective. To describe the clinical, laboratory, radiologic, and histopathologic features of
methotrexate (MTX)‐induced lung injury in a combined cohort of selected patients with …

Objective To compare the clinical and radiographic outcomes in patients with rheumatoid
arthritis (RA) who received monotherapy with either etanercept or methotrexate (MTX) for 2 …

The treatment of rheumatoid arthritis (RA) with methotrexate (MTX) has been a major
advance 38, 40, 52, 57, 60, 61, 62, 63, 66 Methotrexate is now the most commonly used …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal …

Background: Disease-modifying antirheumatic drugs may confer greater benefits when
combined with the antimetabolite methotrexate. Objective: To evaluate the efficacy and …

Objective To examine the degree to which shared risk factors explain the relationship of
periodontitis (PD) to rheumatoid arthritis (RA) and to determine the associations of PD and …

Background: Toxicity limits the use of methotrexate. Objective: To identify risk factors for
methotrexate-induced lung injury in patients with rheumatoid arthritis. Design: Case-control …

Abstract Objective Three 6–12‐month, double‐blind, randomized, controlled trials have
shown leflunomide (LEF; 20 mg/day, loading dose 100 mg× 3 days) to be effective and safe …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with …

Objective The co‐occurrence of rheumatoid factor (RF) and anti–citrullinated protein
antibody (ACPA) positivity in rheumatoid arthritis (RA) is well described. However, the …